Brief: Humacyte Q4 Operating Income USD -28.088 Million Vs. IBES Estimate USD -29.9 Million
28/03/2025 11:30
Mar 28 (Reuters) - Humacyte Q4 operating expenses USD 28.088 million. Q4 basic EPS USD -0.16 Q4 net income USD -20.94 million vs. IBES estimate USD -31.3 million
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary